Development, feasibility testing, and effectiveness evaluation of a group-adapted somatic experiencing intervention in Indonesian female survivors of sexual assault with PTSD symptoms Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 08/11/2024: Development Phase: 1. Psychologists: 1.1. Licensed psychologists with authorization to practice 1.2. Experience in providing interventions for females who have survived sexual violence 2. Somatic Experiencing (SE) Practitioners: 2.1. Specialists with expertise in handling cases of sexual violence 2.2. Experience in conducting group interventions 3. Study Experts from SE Institute: 3.1. Experience designing interventions using the SE method for individuals or groups 3.2. Prior experience in researching SE interventions Feasibility and Effectiveness Phase: 1. Female aged 17 years and above 2. Have experienced sexual assault and exhibit symptoms of Post-Traumatic Stress Disorder (PTSD) 3. Mild to moderately severe PTSD symptoms (PCL-5 score =31) 4. PTSD symptoms are not caused by psychotropic substance use or other psychological conditions 5. Not currently undergoing psychological treatment for PTSD or on medication for less than 1 month 6. No history of alcohol or drug misuse 7. No prior diagnosis of an organic mental health disorder 8. PTSD symptoms must not coincide with or precede a diagnosed medical condition Previous participant inclusion criteria as of 04/11/2024 to 08/11/2024: Development Phase: 1. Psychologists: 1.1. Licensed psychologists with authorization to practice 1.2. Experience in providing interventions for women who have survived sexual violence 2. Somatic Experiencing (SE) Practitioners: 2.1. Specialists with expertise in handling cases of sexual violence 2.2. Experience in conducting group interventions 3. Study Experts from SE Institute: 3.1. Experience designing interventions using the SE method for individuals or groups 3.2. Prior experience in researching SE interventions Feasibility and Effectiveness Phase: 1. Women aged 17 years and above 2. Have experienced sexual assault and exhibit symptoms of Post-Traumatic Stress Disorder (PTSD) 3. Mild to moderately severe PTSD symptoms (PCL-5 score >31) 4. PTSD symptoms are not caused by psychotropic substance use or other psychological conditions 5. Not currently undergoing psychological treatment for PTSD or on medication for less than 1 month 6. No history of alcohol or drug misuse 7. No prior diagnosis of an organic mental health disorder 8. PTSD symptoms must not coincide with or precede a diagnosed medical condition Previous participant inclusion criteria: 1. Women aged 17 years old and above 2. Have experienced sexual assault and show symptoms of Post-Traumatic Stress Disorder (PTSD) 3. Mild to moderately severe PTSD symptoms (PCL-5 score > 31) 4. The PTSD symptoms are not caused by psychotropic substance use or other psychological conditions
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 04/11/2024: Development Phase: 1. Lack of relevant expertise or experience in treating sexual assault cases 2. Inability to commit to the full duration of the development phase activities Feasibility and Effectiveness Phases 1. Currently undergoing psychological treatment for PTSD or on medication for less than 1 month 2. Alcohol or drug misuse 3. Previous diagnosis of an organic mental health disorder 4. PTSD symptoms that precede or coincide with a diagnosed medical condition 5. History of psychosis, brain disorders, or suicidal tendencies 6. Comorbid psychiatric conditions or complex trauma situations characterized by prolonged periods of extreme stress Previous exclusion criteria: 1. Currently in psychological treatment for PTSD on medication for less than 1 2. Alcohol or drug misuse 3. Previous diagnosis of an organic mental health disorder 4. PTSD symptom preceding or coinciding with a diagnosed medical condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PTSD symptoms measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) at baseline, post-treatment (week 10), and follow-up assessments (at 1 and 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Resilience measured using the Connor-Davidson Resilience Scale (CD-RISC-25) at baseline, post-treatment (week 10), and follow-up assessments (at 1 and 3 months) 2. Quality of Life measured using the World Health Organization Quality of Life (WHOQOL-BREF) at baseline, post-treatment (week 10), and follow-up assessments (at 1 and 3 months) | — |
Countries
Indonesia